Solantey just officially flipped over on Yahoo. He owns a few million shares and while that isn't a lot, it has been enough to block us recently with the low volume we've had. There just hasn't been any selling pressure and so he finally made his declaration.
I agree with him. I think we've reached bottom. The LymPro launch will have a magnetic attraction on the pps in the weeks to follow. We up list above .20 cent in December.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links